Lisa Olson

Insider Reports History

Entity
Individual
Location
C/O Magenta Therapeutics, Inc., 100 Technology Square, Cambridge, Massachusetts
Signature
/s/ Cindy Driscoll, Attorney-in-Fact for Lisa Olson
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lisa Olson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Magenta Therapeutics, Inc. Title: Head of Research and Chief Scientific Officer Exhibit 24.1: Power of Attorney Common Stock 14.3 K $171 K $12.00 Sep 16, 2021 Direct
Magenta Therapeutics, Inc. Title: Head of Research and Chief Scientific Officer Exhibit 24.1: Power of Attorney Stock Option (Right to Buy) 100 K Aug 1, 2022 Direct

Insider Reports Filed by Lisa Olson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DNTH Magenta Therapeutics, Inc. Aug 1, 2022 1 $0 4 Aug 1, 2022 Title: Head of Research and Chief Scientific Officer Exhibit 24.1: Power of Attorney
DNTH Magenta Therapeutics, Inc. May 17, 2022 1 $0 4 May 19, 2022 Title: Head of Research and Chief Scientific Officer
DNTH Magenta Therapeutics, Inc. Feb 15, 2022 1 $0 4 Feb 17, 2022 Title: Head of Research and Chief Scientific Officer
DNTH Magenta Therapeutics, Inc. Sep 16, 2021 1 -$38.6 K 4 Sep 20, 2021 Head of Research and Chief Scientific Officer
DNTH Magenta Therapeutics, Inc. Sep 14, 2021 1 $0 4 Sep 16, 2021 Head of Research and Chief Scientific Officer
DNTH Magenta Therapeutics, Inc. Aug 2, 2021 1 $0 4 Aug 3, 2021 Title: Head of Research and Chief Scientific Officer
DNTH Magenta Therapeutics, Inc. Jul 20, 2021 1 $0 4 Jul 22, 2021 Head of Research and Chief Scientific Officer